SMARCA2 and urinary bladder cancer: However, unlike the previous two studies carried out in different cell types, this study found that low expression of the ATPase SMARCA2 (BRM) was found to increase expression of the glycolytic enzyme pyruvate kinase M2 (PKM2), and this correlated with bladder cancer metastasis [54].